Matches in Wikidata for { <http://www.wikidata.org/entity/Q91674904> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91674904 description "article scientifique publié en 2019" @default.
- Q91674904 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91674904 description "scientific article published on 21 May 2019" @default.
- Q91674904 description "wetenschappelijk artikel" @default.
- Q91674904 description "наукова стаття, опублікована 21 травня 2019" @default.
- Q91674904 name "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 name "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 type Item @default.
- Q91674904 label "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 label "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 prefLabel "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 prefLabel "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 P1433 Q91674904-C508906C-B090-4A54-A4EF-B9CDDF7A4715 @default.
- Q91674904 P1476 Q91674904-A5E46CD2-71F7-4B2D-98E9-8C8B2D3E17FF @default.
- Q91674904 P2093 Q91674904-1CE18408-59E1-483C-BB12-97CD3A971131 @default.
- Q91674904 P2093 Q91674904-1E2815E9-60A6-4C96-A30B-7D232C927DE2 @default.
- Q91674904 P2093 Q91674904-3EF4C12C-1B18-4A6C-8E90-186AFE7AED47 @default.
- Q91674904 P2093 Q91674904-61076C4B-AABF-4C51-AB5F-4F91C83DD111 @default.
- Q91674904 P2093 Q91674904-C7FB7C0A-25AA-4B6E-89C8-49A854375529 @default.
- Q91674904 P304 Q91674904-2F29FB44-1E0E-4611-AE47-83F38572E095 @default.
- Q91674904 P31 Q91674904-11494B97-BAA8-47B2-AC91-4CD19BF5E5BA @default.
- Q91674904 P31 Q91674904-f78475a4-b628-4e5e-9aad-514ff64b290f @default.
- Q91674904 P356 Q91674904-EE3E1B4C-1BDB-4131-AB4A-10120DE6EBBA @default.
- Q91674904 P433 Q91674904-55309392-03FD-43A9-BC68-5EBFC08DFEB2 @default.
- Q91674904 P478 Q91674904-9B48322F-D899-445D-ACA5-B273D95224D9 @default.
- Q91674904 P577 Q91674904-531B07E8-1C57-4C15-9641-752D4010C45D @default.
- Q91674904 P698 Q91674904-4FD063CC-1193-4736-9D7F-C743517FEF30 @default.
- Q91674904 P921 Q91674904-DB61403B-3F48-47C6-8FA6-0D8D8A8EE5DB @default.
- Q91674904 P921 Q91674904-FE88348C-86F2-4806-A9B4-A8DF62E91784 @default.
- Q91674904 P356 J.CLGC.2019.05.003 @default.
- Q91674904 P698 31279483 @default.
- Q91674904 P1433 Q332266 @default.
- Q91674904 P1476 "The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis" @default.
- Q91674904 P2093 "Guiqian Zhang" @default.
- Q91674904 P2093 "Jiejing Li" @default.
- Q91674904 P2093 "Xiangcai Yang" @default.
- Q91674904 P2093 "Xin Fan" @default.
- Q91674904 P2093 "Yi Sun" @default.
- Q91674904 P304 "e847-e859" @default.
- Q91674904 P31 Q13442814 @default.
- Q91674904 P31 Q7318358 @default.
- Q91674904 P356 "10.1016/J.CLGC.2019.05.003" @default.
- Q91674904 P433 "5" @default.
- Q91674904 P478 "17" @default.
- Q91674904 P577 "2019-05-21T00:00:00Z" @default.
- Q91674904 P698 "31279483" @default.
- Q91674904 P921 Q1164529 @default.
- Q91674904 P921 Q19000948 @default.